Awarded
SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: INFLIXIMAB (REMSIMA), LABETALOL (TRANDATE).
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- KERN PHARMA, S.L.
- Contract value
- €88,546
- Bids received
- 1
- Published
- 24 Sept 2025
- Awarded
- 8 Aug 2025
- Contract start
- 8 Aug 2025
- Contract end
- 9 Aug 2026estimated
- Region
- Madrid